Figure 5
Consent for optional study events. Carrier status: reporting of germline carrier status for recessive diseases. Additional tumor: use of diagnostic tumor for additional research studies. Subsequent tumor: use of tumor from subsequent surgeries for additional research studies. Additional blood: collection of blood sample for additional research studies. Data sharing: sharing of study samples and/or de-identified genetic/clinical data with other investigators for IRB-approved studies. Database deposit: deposition of de-identified genetic/clinical data into scientific databases. Future re-contact: to obtain follow-up clinical information or request additional study samples.